Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials
View/ Open
Author
Treasure, Graham C.
Aga, Evgenia
Mellors, John W.
Para, Michael
Published Version
https://doi.org/10.1097/QAI.0000000000000964Metadata
Show full item recordCitation
Treasure, Graham C., Evgenia Aga, Ronald J. Bosch, John W. Mellors, Daniel R. Kuritzkes, Michael Para, Rajesh T. Gandhi, and Jonathan Z. Li. 2016. “Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.” Journal of Acquired Immune Deficiency Syndromes (1999) 72 (3): 310-313. doi:10.1097/QAI.0000000000000964. http://dx.doi.org/10.1097/QAI.0000000000000964.Abstract
Abstract: Viral load (VL) rebound timing and set point were analyzed in 235 participants undergoing analytic treatment interruption (ATI) in 6 AIDS Clinical Trials Group studies. There was no significant association between rebound timing and ATI VL set point for those who rebounded ≤12 weeks. VL set points were lower in participants with rebound >12 weeks (P < 0.001) and participants treated during early infection (P < 0.001). Pre-antiretroviral therapy VL correlated with set point, though 68% of participants had a set point lower than pre-antiretroviral therapy VL. These results illustrate complex relationships between post-ATI virologic outcomes and the potential presence of biological factors mediating rebound timing and set point.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911279/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:27822404
Collections
- HMS Scholarly Articles [17928]
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)